Looking to publish in Advances in Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginAdvances in Therapy is an international, hybrid, peer-reviewed single-blind journal covering therapies, devices, and surgical techniques across all therapy areas. It emphasizes rapid publication, broad inclusion of scientifically sound research including positive, confirmatory, and negative data, and accepts work from clinical phase, real-world, and health economics outcomes studies for both international and country-specific audiences.
Looking to publish in Advances in Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Advances in Therapy accepts the following article types. Click on an article type to view submission instructions.
Original Research
Reviews
Narrative Review
Systemic Review
Brief Reports
Case Series
Guidelines
Letters To The Editor
Recent Publications
Rocbrutinib, a Highly Selective Fourth-Generation Covalent and Noncovalent BTK Inhibitor, in R/R Non-GCB DLBCL: Efficacy and Safety from a Phase I Study
Ningjing Lin, Qingqing Cai, Keshu Zhou, Xiuhua Sun, Kaiyang Ding, Lei Zhang, Zhengming Jin, Ming Jiang, Zhigang Peng, Lanfang Li, Wei Yang, Min Zhou, Yuankai Shi, Zheng Wang, Nawei Liu, Yejiang Lou, Yue Shen, Yi Chen, Fenlai Tan, Yuqin Song, Jun Zhu
Long-Acting Cabotegravir Injections Are More Acceptable Than Long-Acting Lenacapavir Injections After One Dose: Results From the CLARITY Randomized Crossover Study
Emilie R. Elliot, Justine Boles, Dainielle Fox, Katherine L. Nelson, Laure Dupont-Benjamin, Apinya Vutikullird, Amber Mottola, Kim Fletcher, Kehui Wang, Suryakant Somvanshi, Richard Grove, Katie Strano, Nanlesta Pilgrim, Rebecca Borsi, Piotr Budnik, Jean van Wyk, Harmony P. Garges, Kimberley Brown
Correction: The Impact of Untreated Attention-Deficit/Hyperactivity Disorder on Motor Vehicle Accidents: A Systematic Review and Meta-Analysis
Ann Childress, Hirah Malik, Jim Potenziano
Regional Citrate Anticoagulation Versus No Anticoagulation During Continuous Renal Replacement Therapy in Critically Ill Patients at High Risk of Bleeding: A Meta-analysis of Randomized Controlled Trials
Wenlong Li, Jun Xie, Chong Huang, Chengyun Xu, Yan Chen
A Matching-Adjusted Indirect Comparison of PET-Guided BrECADD Versus PET-Guided ABVD, BEACOPP, and eBEACOPP in Advanced Hodgkin Lymphoma
Alexa Molinari, Fjoralba Kristo, Victoria Paly, Zhiyi Lan, Athanasios Zomas, Vanessa Stache, Zijiao Yuan, Abbey Poirier, Christian Jaworek, Hishan Tharmaseelan, Hoora Moradian, Thomas Melchardt
Frequently asked questions
How long does it take to publish?
The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online, and reports a median of 2 days from submission to first decision.
Reformat to Advances in Therapy using Livewrite PremiumWhat are the publication costs?
Open access APC: £3090.00 GBP / $4990.00 USD / €3990.00 EUR. Subscription publishing: no APC.
Reformat to Advances in Therapy using Livewrite Premium